Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization in Patients With Selected Solid Tumors
Clinical trial NCT02451007 · COMPLETED
Trial details
- NCT number
- NCT02451007
- Sponsor
- PharmaMar
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-12
- Primary completion
- 2016-08-19
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.